Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery
SupersonicOR
Quantitative Evaluation of Liver Disease With Liver Elastography Measurements Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine in Patients Undergoing Liver Transplant Surgery
1 other identifier
observational
13
1 country
1
Brief Summary
The purpose of the study is to compare ultrasound measurements of the liver obtained prior to surgery on the skin to measurements obtained during surgery directly on the diseased liver. The objective is to determine if ultrasounds of the liver on the skin can provide accurate measurements of disease of the liver to provide an alternative option to liver biopsies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 27, 2013
CompletedFirst Posted
Study publicly available on registry
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedJanuary 22, 2016
January 1, 2016
2.1 years
June 27, 2013
January 21, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
To obtain quantitative evaluation of the progression of liver disease, using ShearWaveTM Elastography measurements obtained with the Supersonic Imagine Aixplorer ultrasound machine in patients undergoing a liver transplant surgery.
on day of surgery
Eligibility Criteria
Patients undergoing a liver transplant surgery
You may qualify if:
- Males and Females over the age of 18
- Patients undergoing a liver transplant surgery
You may not qualify if:
- Any person unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor University Medical Center
Dallas, Texas, 75246, United States
Study Officials
- PRINCIPAL INVESTIGATOR
James Trotter, MD
Baylor Health Care System
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2013
First Posted
July 1, 2013
Study Start
June 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
January 22, 2016
Record last verified: 2016-01